OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations
Hiroshi Miyata, Tappei Takada, Yu Toyoda, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 123

Showing 26-50 of 123 citing articles:

Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients
Yuki Ohashi, Masao Toyoda, Nobumichi Saito, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14

Uric acid transport, transporters, and their pharmacological targeting
Emmanuel A. Adomako, Orson W. Moe
Acta Physiologica (2023) Vol. 238, Iss. 2
Open Access | Times Cited: 14

Early-onset gout
Tristan Pascart, Vincent Ducoulombier, Charlotte Jauffret
Joint Bone Spine (2024) Vol. 91, Iss. 5, pp. 105704-105704
Open Access | Times Cited: 5

Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis
Mary Wallace, Rebecca L Roberts, Payal Nanavati, et al.
Lara D. Veeken (2017) Vol. 57, Iss. 4, pp. 656-660
Open Access | Times Cited: 48

Discovery of novel verinurad analogs as dual inhibitors of URAT1 and GLUT9 with improved Druggability for the treatment of hyperuricemia
Zean Zhao, Jin Liu, Peihua Kuang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 114092-114092
Closed Access | Times Cited: 32

Hypouricemic agents reduce indoxyl sulfate excretion by inhibiting the renal transporters OAT1/3 and ABCG2
Tetsuya Taniguchi, Koichi Omura, Keisuke Motoki, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 29

Urate Transporter 1 Can Be a Therapeutic Target Molecule for Chronic Kidney Disease and Diabetic Kidney Disease: A Retrospective Longitudinal Study
Hidekatsu Yanai, Hisayuki Katsuyama, Mariko Hakoshima, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 567-567
Open Access | Times Cited: 12

Allopurinol, Febuxostat, and Nonuse of Xanthine Oxidoreductase Inhibitor Treatment in Patients Receiving Hemodialysis: A Longitudinal Analysis
Takeo Ishii, Nodoka Seya, Masataka Taguri, et al.
Kidney Medicine (2024) Vol. 6, Iss. 11, pp. 100896-100896
Open Access | Times Cited: 4

Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate Rosuvastatin
Minna Lehtisalo, Jenni E. Keskitalo, Aleksi Tornio, et al.
Clinical and Translational Science (2020) Vol. 13, Iss. 6, pp. 1236-1243
Open Access | Times Cited: 31

Omega-3 Polyunsaturated Fatty Acids Inhibit the Function of Human URAT1, a Renal Urate Re-Absorber
Hiroki Saito, Yu Toyoda, Tappei Takada, et al.
Nutrients (2020) Vol. 12, Iss. 6, pp. 1601-1601
Open Access | Times Cited: 30

OAT10/SLC22A13 Acts as a Renal Urate Re-Absorber: Clinico-Genetic and Functional Analyses With Pharmacological Impacts
Yu Toyoda, Yusuke Kawamura, Akiyoshi Nakayama, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18

ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives
Daniela Damiani, Mario Tiribelli
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7147-7147
Open Access | Times Cited: 10

A non-purine inhibitor of xanthine oxidoreductase mitigates adenosine triphosphate degradation under hypoxic conditions in mouse brain
Nana Sato, Teruo Kusano, Koji Nagata, et al.
Brain Research (2025), pp. 149444-149444
Closed Access

Litiasis úrica
A. Pruna, M. Daudon
EMC - Urología (2025) Vol. 57, Iss. 1, pp. 1-22
Closed Access

GLUT2/SLC2A2 is a bi-directional urate transporter
Yu Toyoda, Ryuichiro Shigesawa, Tony R. Merriman, et al.
Journal of Biological Chemistry (2025), pp. 108485-108485
Open Access

Apoptozole Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer
Kai Zeng, Qinghua Zhou, Yun-Xi Zhang, et al.
Journal of cancer research updates (2025) Vol. 14, pp. 63-68
Closed Access

Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study
Tatsuo Hosoya, Takafumi Sano, Tomomitsu Sasaki, et al.
Clinical and Experimental Nephrology (2020) Vol. 24, Iss. S1, pp. 62-70
Open Access | Times Cited: 26

Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout
Yu Toyoda, Kateřina Pavelcová, Jana Bohatá, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1935-1935
Open Access | Times Cited: 22

Urate transport in health and disease
Victoria L. Halperin Kuhns, Owen M. Woodward
Best Practice & Research Clinical Rheumatology (2021) Vol. 35, Iss. 4, pp. 101717-101717
Open Access | Times Cited: 22

ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?
Daniela Damiani, Mario Tiribelli
Biomedicines (2024) Vol. 12, Iss. 1, pp. 111-111
Open Access | Times Cited: 3

Scroll to top